I liked the news that Chiral will be contacting the 1400 hospitals to see if they want to stock Leronlimab in their hospitals. We know they are approved for 100 patients each or 400 doses. Future revenue that is substantial can’t be that far away.

I also liked the marketing agreements coming for strong partner in Europe and the Middle East soon.

The dominos are lining up... when will the first EUA fall and knock down the row of dominos giving us sales in all these countries we are aligning with these partnerships. Will it happen prior to interim results or will we have to wait for the interim results?